photo of Lenore Goldfarb
recurrent miscarriage

References for: Causes, evaluation, and treatment.

Medscape Women’s Health 1998 May;3(3):2 (ISSN: 1521-2076) Bick RL; Madden J; Heller KB; Toofanian A

Thrombosis Clinical Center, Department of Medicine (Hematology & Oncology), Presbyterian Hospital of Dallas, Tex., USA.

Table 1. Profile of 118 Women Having Recurrent Fetal Loss

Mean Age: 34 years
Mean Number of Miscarriages at Diagnosis: 3
Frequency of Defects Noted
Antiphospholipid syndrome: 50 (62.50%)
SPS: 13 (16.20%)
Protein S deficiency: 7 (8.70%)
TPA deficiency: 7 (8.70%)
APC resistance: 2 (2.50%)
PAI-1 defect: 1 (1.25%)
APC = activated protein C PAI-1 = type 1 plasminogen activator
SPS = sticky platelet syndrome TPA = tissue plasminogen activator

Table 2. Two-Stage Evaluation of RFL When Blood-Protein and Platelet Defects Are Suspected

Blood-Protein/Platelet Factor (Technique/Assay)
Stage I
Perform complete history and physical exam. Send serum for CBC and panel I blood protein and coagulation studies.
Panel I
  • Prothrombin time
  • Activated partial thromboplastin time
  • Anticardiolipin antibodies (solid-phase ELISA) IgG, IgA, IgM idiotypes
  • Lupus anticoagulant with phospholipid confirmation (dRVVT)
  • Functional protein S (immunologic and free)
  • C4b-binding protein (if functional protein S is low)
  • Protein C (chromogenic technique)
  • Factor XIII (immunoassay)
  • Antithrombin (chromogenic technique)
  • Sticky platelet syndrome (SPS)
  • Plasminogen (chromogenic technique)
  • Activated protein C resistance (Dahlback method16)
  • Functional fibrinogen
Stage II
Evaluate serum sample for blood protein defects more rarely associated with RFL.
Panel II
  • Plasminogen activator inhibitor type 1 (PAI-1)
  • Tissue plasminogen activator
  • Heparin cofactor II
  • Tissue factor pathway inhibitor
  • Blood and urine homocysteine

dRVVT= dilute Russel’s viper venom time; ELISA = enzyme-linked immunosorbent assay; Ig = immunoglobulin.

print this page back

If you value this service, kindly consider a donation to the Canadian Breastfeeding Foundation (registered charity). Earmark the donation for the International Breastfeeding Centre (Newman Breastfeeding Clinic) and/or the Goldfarb Breastfeeding Program.

Donate online:

Donate by mail: Canadian Breastfeeding Foundation, 5890 Monkland Ave, Suite 16, Montreal, Quebec, Canada H4A 1G2.

© 2002-2019 Lenore Goldfarb, PhD, CCC, IBCLC, ALC and contributing authors to All rights reserved.

Disclaimer: The information provided on this website is for general informational purposes only and does not constitute medical advice. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis, or treatment. If you have any specific questions or concerns about any health issue, you should consult with a qualified healthcare provider.
The AskLenore administration is not affiliated with, nor sponsored by, nor do we sell or receive any commissions or incentives from, any of the products or services that we link to on this website. Therefore, we are not responsible for the accuracy, quality, availability, or suitability of said products or services. You should always do your own research and due diligence before purchasing or using any product or service that we link to on this website.
The views and opinions expressed on the message boards are those of the authors and do not necessarily reflect the official policy or position of Any content provided by our users are of their opinion and are not intended to malign any religion, ethnic group, club, organization, company, individual or anyone or anything.